» Articles » PMID: 29156950

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

Overview
Publisher Sage Publications
Date 2017 Nov 22
PMID 29156950
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

TYK2 in Immune Responses and Treatment of Psoriasis.

Shang L, Cao J, Zhao S, Zhang J, He Y J Inflamm Res. 2022; 15:5373-5385.

PMID: 36147687 PMC: 9488612. DOI: 10.2147/JIR.S380686.


Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.

Smith M, Pai J, Panaccione R, Beck P, Ferraz J, Jijon H BMC Gastroenterol. 2019; 19(1):162.

PMID: 31488067 PMC: 6727530. DOI: 10.1186/s12876-019-1067-0.